Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hayes

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Vaccine|September 7, 2010
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjectsSarah Howles, Ana Guimarães-Walker, Hongbing Yang, et al.
Journal of the American College of Cardiology|June 12, 2003
Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndromeDavid A Elliott, Edwin P Kirk, Thomas Yeoh, et al.
BMC Primary Care|April 26, 2025
Identifying research priorities for chronic disease management in primary care: results of an Irish James Lind Alliance Priority Setting PartnershipLaura O'Connor, Sarah Delaney, Michelle Hanlon, et al.
Plos One|November 17, 2021
Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide setPeter Hayes, Natalia Fernandez, Christina Ochsenbauer, et al.
Plos One|October 15, 2013
Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individualsHenrik N Kløverpris, Akil Jackson, Amanda Handley, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 31, 2019
Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary carePeter Hayes, Monica Casey, Liam G Glynn, et al.
Hepatology (Baltimore, Md.)|September 11, 2012
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectivenessHamish A Innes, Sharon J Hutchinson, Stephen Barclay, et al.
Plos One|September 27, 2013
A randomised, placebo-controlled, first-in-human study of a novel clade C therapeutic peptide vaccine administered ex vivo to autologous white blood cells in HIV infected individualsAkil Jackson, Henrik N Kløverpris, Marta Boffito, et al.
Plos One|March 11, 2014
Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsJakub Kopycinski, Peter Hayes, Ambreen Ashraf, et al.
BMC Family Practice|February 7, 2020
The University of Limerick Education and Research Network for General Practice (ULEARN-GP): practice characteristics and general practitioner perspectivesAndrew O'Regan, Peter Hayes, Ray O'Connor, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Vaccine|September 7, 2010
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjectsSarah Howles, Ana Guimarães-Walker, Hongbing Yang, et al.
Journal of the American College of Cardiology|June 12, 2003
Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndromeDavid A Elliott, Edwin P Kirk, Thomas Yeoh, et al.
BMC Primary Care|April 26, 2025
Identifying research priorities for chronic disease management in primary care: results of an Irish James Lind Alliance Priority Setting PartnershipLaura O'Connor, Sarah Delaney, Michelle Hanlon, et al.
Plos One|November 17, 2021
Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide setPeter Hayes, Natalia Fernandez, Christina Ochsenbauer, et al.
Plos One|October 15, 2013
Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individualsHenrik N Kløverpris, Akil Jackson, Amanda Handley, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 31, 2019
Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary carePeter Hayes, Monica Casey, Liam G Glynn, et al.
Hepatology (Baltimore, Md.)|September 11, 2012
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectivenessHamish A Innes, Sharon J Hutchinson, Stephen Barclay, et al.
Plos One|September 27, 2013
A randomised, placebo-controlled, first-in-human study of a novel clade C therapeutic peptide vaccine administered ex vivo to autologous white blood cells in HIV infected individualsAkil Jackson, Henrik N Kløverpris, Marta Boffito, et al.
Plos One|March 11, 2014
Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsJakub Kopycinski, Peter Hayes, Ambreen Ashraf, et al.
BMC Family Practice|February 7, 2020
The University of Limerick Education and Research Network for General Practice (ULEARN-GP): practice characteristics and general practitioner perspectivesAndrew O'Regan, Peter Hayes, Ray O'Connor, et al.
Pageof 13